APLS - Apellis Pharmaceuticals, Inc.
20.07
-0.080 -0.399%
Share volume: 1,627,206
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$20.15
-0.08
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-01-2024 | 11-05-2024 | 02-28-2025 | 05-07-2025 | 07-31-2025 | 10-30-2025 | 02-24-2026 | |
| Assets | |||||||||
| Total Assets | 831.930 M | 904.482 M | 901.866 M | 885.051 M | 807.285 M | 821.390 M | 1.059 B | 1.075 B | |
| Current Assets | 811.428 M | 859.974 M | 833.897 M | 788.954 M | 727.718 M | 755.610 M | 990.676 M | 1.015 B | |
| Inventories | 161.283 M | 152.772 M | 121.058 M | 81.404 M | 82.468 M | 121.000 M | 122.819 M | 142.556 M | |
| Other Current Assets | 12.119 M | 12.372 M | 11.782 M | 11.644 M | 13.073 M | 19.842 M | 10.158 M | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 325.923 M | 360.087 M | 396.864 M | 411.290 M | 358.393 M | 370.036 M | 479.171 M | 466.233 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.195 M | 3.836 M | 3.379 M | 2.952 M | 2.514 M | 2.117 M | 1.927 M | 1.708 M | |
| Other Assets | 16.307 M | 40.672 M | 64.590 M | 93.145 M | 77.053 M | 63.663 M | 66.120 M | 58.709 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 831.930 M | 904.482 M | 901.866 M | 885.051 M | 807.285 M | 821.390 M | 1.059 B | 1.075 B | |
| Total liabilities | 565.254 M | 640.155 M | 664.745 M | 656.512 M | 643.069 M | 665.085 M | 657.555 M | 705.110 M | |
| Total current liabilities | 215.291 M | 169.168 M | 191.260 M | 185.509 M | 178.377 M | 200.659 M | 279.527 M | 323.596 M | |
| Accounts Payable | 26.788 M | 38.270 M | 42.730 M | 38.572 M | 55.287 M | 54.241 M | 38.602 M | 56.798 M | |
| Other liabilities | 256.854 M | 13.776 M | 21.240 M | 18.173 M | 11.270 M | 10.391 M | 16.937 M | 19.850 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 93.109 M | 457.211 M | 452.245 M | 452.830 M | 453.422 M | 454.035 M | 361.091 M | 361.664 M | |
| Other liabilities | 256.854 M | 13.776 M | 21.240 M | 18.173 M | 11.270 M | 10.391 M | 16.937 M | 19.850 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 266.676 M | 264.327 M | 237.121 M | 228.539 M | 164.216 M | 156.305 M | 401.168 M | 370.147 M | |
| Common stock | 3.174 B | 3.209 B | 3.239 B | 3.267 B | 3.295 B | 3.329 B | 3.358 B | 3.385 B | |
| Retained earnings | -2.904 B | -2.942 B | -2.999 B | -3.035 B | -3.128 B | -3.170 B | -2.954 B | -3.013 B |